Official store is canadasteroiddepot.is — beware of fake sites. We only sell from this domain!
Ships from within Canada | Discreet Packaging | No Customs

Winstrol 25mg - 50 Tablets

★★★★★ 4.5 · 4 reviews SKU FB51 99% HPLC purity
$82.68
In stock — dispatches within 24h, tracked

Winstrol (Stanozolol) 25mg is an oral anabolic steroid formulation supplied in a 50 tablet pack. Manufactured for consistent potency, stability, and research applications.

Format50 Tablets
Concentration25mg
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery

Stanozolol, widely known by its pharmaceutical brand name Winstrol, is a synthetic anabolic compound derived from dihydrotestosterone (DHT) with a well documented history in both pharmaceutical and sports science research. F40 Biotech’s 25mg formulation delivers a higher unit dose than CSD’s Axon Pharma Corp 20mg Winstrol listing in a 50 count format, providing researchers with a higher concentration tablet option suited to protocols examining mid to upper range Stanozolol dose response relationships where a higher unit dose reduces tablet count per administration across the protocol timeline.

The 25mg versus 20mg concentration difference is the primary research selection variable between CSD’s two oral Winstrol listings. The Axon Pharma Corp 20mg presentation supports more precise low dose titration, while this F40 Biotech 25mg format offers a higher unit dose with extended supply duration per pack; both delivering identical base compound pharmacology including the unique pyrazole ring structural modification that distinguishes Stanozolol from all other anabolic steroids, complete non aromatization as a DHT derivative, and the well documented oral versus injectable SHBG suppression divergence that makes Stanozolol a frequently studied subject in route of administration comparative research.

CSD stocks Stanozolol across three presentations,  Axon Pharma Corp 20mg oral tablets, this F40 Biotech 25mg oral tablets, and an injectable Stanozolol 50mg/mL 10mL vial giving researchers the ability to compare unit dose, manufacturer, and delivery route within the same compound from a single verified Canadian supplier. The oral versus injectable distinction is particularly well studied for Stanozolol given its documented divergent effects on SHBG suppression between administration routes at equivalent doses.

F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and F40 Biotech’s Stanozolol meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Store in a cool, dry place away from direct light and heat. Intended for research purposes only.

Commonly researched alongside testosterone base compounds and liver support compounds. Browse CSD’s full oral and injectable range and PCT compounds for complete protocol sourcing.

Verified buyers

Customer reviews

Write a review →
4.5
★★★★★
Based on 4 verified reviews
5★75%
4★0%
3★25%
2★0%
1★0%
★★★★★ John C. Verified buyer 2025-08-04

★★★★★ Mark Verified buyer 2025-05-06

Fantastic product. Works well. One tab a day worked for me. Quick shipping.

★★★☆☆ Anonymous Verified buyer 2025-02-19

★★★★★ Anonymous Verified buyer 2025-01-31

Write a review

Good to know

Frequently asked questions

Winstrol (Stanozolol) is a 17-alpha alkylated DHT derivative with a high anabolic to androgenic ratio that does not aromatize to estrogen and has no progestin activity; making it one of the most studied oral anabolic compounds for cutting and lean mass research. It is researched for muscle hardness, vascularity, strength enhancement, and lean mass preservation in caloric deficit protocols. Stanozolol uniquely and significantly lowers SHBG, increasing the free testosterone ratio in concurrent compound protocols. It has a severe negative impact on lipid profiles, markedly reducing HDL while elevating LDL. Making lipid monitoring and management an essential component of any Stanozolol research protocol.

The active compound is identical, Stanozolol but the 25mg tablet provides a slightly higher per tablet dose than the 20mg version. Common male research doses of 50mg daily are achievable with two 25mg tablets. A clean, straightforward two tablet daily dose without requiring three tablets as the 20mg version would for a 60mg daily protocol. The 25mg dose also aligns with the most commonly studied male Winstrol dose of 50mg daily more cleanly than the 20mg tablet, and provides a 12.5mg half-tablet option for female research protocols targeting conservative doses.

Stanozolol has a half-life of approximately 8–9 hours, typically administered in two divided daily doses for stable plasma levels. For male research protocols, the most common daily dose of 50mg is achieved with two 25mg tablets split morning and afternoon. Some protocols use a single daily 50mg dose for simplicity given the compound's relatively long oral half-life. The 50 tablet pack at 25mg provides 1250mg total; sufficient for 25 days of male research at 50mg daily or 50 days at 25mg daily. Research cycle duration is typically limited to 6 weeks maximum for oral Stanozolol due to cumulative lipid and hepatic effects.

Stanozolol has the most severe negative impact on HDL cholesterol of any commonly researched oral anabolic compound; significantly reducing HDL while elevating LDL and triglycerides. Lipid monitoring before, during, and after Stanozolol research protocols is strongly recommended. Pharmaceutical grade Omega 3 fatty acids at 3–4g EPA+DHA daily and Rosuvastatin are the most commonly researched lipid management interventions. Liver support with TUDCA at 500mg daily is also recommended given Stanozolol's 17-AA hepatotoxicity. Research cycle duration should be strictly limited to 6 weeks maximum for oral Stanozolol.

Yes! This batch has been independently HPLC tested by an accredited third party laboratory confirming concentration accuracy at 25mg per tablet and compound identity as Stanozolol. A certificate of analysis is available.

Main Menu

Winstrol 25mg - 50 Tablets

Winstrol 25mg - 50 Tablets